Aerobic Endurance Training vs. Relaxation Training in Patients With Migraine
ARMIG
Aerobic Endurance Training Versus Relaxation Training in Migraine Prophylaxis
1 other identifier
interventional
56
1 country
1
Brief Summary
This is a single centre, open label, prospective, randomized study on the prophylactic effect of moderate aerobic endurance training versus relaxation training in patients with migraine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 1, 2011
CompletedFirst Posted
Study publicly available on registry
August 2, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedDecember 3, 2014
December 1, 2014
3.3 years
August 1, 2011
December 2, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction of headache days in the last 4 weeks of the 12-week training compared to baseline (4 weeks before start of the training).
16 weeks
Secondary Outcomes (5)
Number of headache days 12 weeks after finishing the training (follow up).
20 weeks
Consumption of analgetic agents/triptans
20 weeks
Increase in aerobic capability
12 weeks
Impact on burden of disease
20 weeks
Psychological Impact of Training
20
Study Arms (2)
Relaxation training
ACTIVE COMPARATORPatients participate in a relaxation training program under expert guidance at least three times a week over 12 weeks.
Aerobic endurance training
ACTIVE COMPARATORPatients participate in a moderate aerobic endurance training program under expert guidance three times a week over 12 weeks.
Interventions
Patients participate in a relaxation training program under expert guidance at least three times a week over 12 weeks.
Patients participate in a moderate aerobic endurance training program under expert guidance three times a week over 12 weeks.
Eligibility Criteria
You may qualify if:
- Patient's signature on the informed consent document \[each patient should be given ample time to read (or have read to them) the consent form, ask any questions they may have regarding the trial and have a clear understanding of the trial and the procedures involved prior to the signing of the consent form\].
- Patients have a clinical diagnosis of migraine with or without aura according to IHS criteria at least one year prior to enrollment.
- Patients have a clinical diagnosis of migraine with or without aura and in addition a clinical diagnosis of tension type headache according to IHS criteria, if patients are able to differentiate between the two headache diagnoses and if migraine is more frequent in these patients
- Patients that report at least three headache days per month
You may not qualify if:
- Diseases or disabilities that disqualify to perform either aerobic endurance training or relaxation training
- Language difficulties that disable to fill out questionnaires
- Pregnancy
- Additional diagnosis of secondary headache according to the IHS criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurology, University of Duisburg-Essen
Essen, 45147, Germany
Related Publications (1)
Totzeck A, Unverzagt S, Bak M, Augst P, Diener HC, Gaul C. Aerobic endurance training versus relaxation training in patients with migraine (ARMIG): study protocol for a randomized controlled trial. Trials. 2012 Apr 27;13:46. doi: 10.1186/1745-6215-13-46.
PMID: 22540391DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charly Gaul, MD
Department of Neurology, University of Duisburg-Essen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. of Neurology
Study Record Dates
First Submitted
August 1, 2011
First Posted
August 2, 2011
Study Start
July 1, 2011
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
December 3, 2014
Record last verified: 2014-12